Friday, June 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

1st Detect Awarded Phase II of Next Generation Chemical Detector Program

by Global Biodefense Staff
July 8, 2015

1st Detect Corporation, a subsidiary of Astrotech ASTC, this week announced that its breakthrough portable mass spectrometer technology has reached another milestone in the military’s three-phase, multi-year Next Generation Chemical Detector (NGCD) development program.

Together with Battelle, 1st Detect has officially entered the phase II test and evaluation process for its prototype Multi-Sample Identifier Detector (MSID) solution.

The Department of Defense NGCD program is designed to develop and procure advanced detectors for Chemical Warfare Agents, Toxic Industrial Chemicals, and Non-Traditional Agents. The detectors are intended for use by the military for a wide range of missions.

“Reaching this second phase of the NGCD project is a vote of confidence in the viability of 1st Detect’s mass spectrometer detection solution. It provides us with an inimitable opportunity to refine the solution in a way that will meet the challenging needs of our military and effectively save lives,” explained Thomas B. Pickens III, CEO of Astrotech. “We are working in close collaboration with our key partner Battelle to validate and refine our joint detection solution, and we’ll continue to leverage their elaborate biological and chemical defense expertise to advance the solution to the final phase with the government,” he added.

The mass spectrometer instrument developed by 1st Detect Corporation has revolutionized the chemical detection and analysis market by delivering lab performance mass spectrometry in a miniaturized, affordable and easily portable package.

The 1st Detect mass spectrometer is capable of detecting a wide variety of chemicals including residues and vapors from explosives, chemical warfare agents, toxic chemicals, food and beverage contaminants, and pollutants. These abilities make it an ideal tool for a variety of applications in the research, security, industrial, process flow and healthcare markets.

“We are pleased to see that the tremendous research and development efforts of our technical Program Team have proved successful, ultimately translating into technical detection solutions advanced enough to satisfy the extensive requirements and milestones set forth by our government,” stated Bob Kibler, CEO of 1st Detect.

1st Detect Corporation was initially formed to develop and commercialize miniature mass spectrometer technology first developed under an agreement with NASA for use on the International Space Station. This miniaturized mass spectrometer fills an unmet need by being highly accurate, rapid, lightweight, and cost-effective.

Tags: AwardsBattelleChemical Detection

Related Posts

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy